Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bissett

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
British Journal of Cancer|February 13, 2001
Phase I dose-escalation and pharmacokinetic study of a novel folate analogue AG2034D Bissett, H L McLeod, B Sheedy, et al.
Journal of the National Cancer Institute|April 1, 1992
Preclinical and phase I studies with rhizoxin to apply a pharmacokinetically guided dose-escalation schemeM A Graham, D Bissett, A Setanoians, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
A Phase I study of capecitabine in combination with oral leucovorin in patients with intractable solid tumorsJ Cassidy, L Dirix, D Bissett, et al.
British Journal of Cancer|October 1, 1990
Long-term sequelae of treatment for testicular germ cell tumoursD Bissett, L Kunkeler, L Zwanenburg, et al.
British Journal of Cancer|June 1, 1995
Phase I study of accelerated FEC with granulocyte colony-stimulating factor (Lenograstim) supportD Bissett, D Jodrell, A N Harnett, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1995
Epirubicin chemotherapy and advanced breast cancer after adjuvant CMF chemotherapyD Bissett, J Paul, G Wishart, et al.
Antimicrobial Agents and Chemotherapy|March 29, 2017
Effect of a Health Care System Respiratory Fluoroquinolone Restriction Program To Alter Utilization and Impact Rates of Clostridium difficile InfectionKatherine M Shea, Athena L V Hobbs, Theresa C Jaso, et al.
Emerging Infectious Diseases|August 31, 2018
Detection of Tickborne Relapsing Fever Spirochete, Austin, Texas, USAJack D Bissett, Suzanne Ledet, Aparna Krishnavajhala, et al.
Cancer Research|May 15, 1992
Phase I and pharmacokinetic study of rhizoxinD Bissett, M A Graham, A Setanoians, et al.
Cancer Research|May 15, 1995
Phase I clinical and pharmacokinetic study of 3'-deamino-3'-(2-methoxy-4-morpholinyl)doxorubicin (FCE 23762)P A Vasey, D Bissett, M Strolin-Benedetti, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
British Journal of Cancer|February 13, 2001
Phase I dose-escalation and pharmacokinetic study of a novel folate analogue AG2034D Bissett, H L McLeod, B Sheedy, et al.
Journal of the National Cancer Institute|April 1, 1992
Preclinical and phase I studies with rhizoxin to apply a pharmacokinetically guided dose-escalation schemeM A Graham, D Bissett, A Setanoians, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
A Phase I study of capecitabine in combination with oral leucovorin in patients with intractable solid tumorsJ Cassidy, L Dirix, D Bissett, et al.
British Journal of Cancer|October 1, 1990
Long-term sequelae of treatment for testicular germ cell tumoursD Bissett, L Kunkeler, L Zwanenburg, et al.
British Journal of Cancer|June 1, 1995
Phase I study of accelerated FEC with granulocyte colony-stimulating factor (Lenograstim) supportD Bissett, D Jodrell, A N Harnett, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1995
Epirubicin chemotherapy and advanced breast cancer after adjuvant CMF chemotherapyD Bissett, J Paul, G Wishart, et al.
Antimicrobial Agents and Chemotherapy|March 29, 2017
Effect of a Health Care System Respiratory Fluoroquinolone Restriction Program To Alter Utilization and Impact Rates of Clostridium difficile InfectionKatherine M Shea, Athena L V Hobbs, Theresa C Jaso, et al.
Emerging Infectious Diseases|August 31, 2018
Detection of Tickborne Relapsing Fever Spirochete, Austin, Texas, USAJack D Bissett, Suzanne Ledet, Aparna Krishnavajhala, et al.
Cancer Research|May 15, 1992
Phase I and pharmacokinetic study of rhizoxinD Bissett, M A Graham, A Setanoians, et al.
Cancer Research|May 15, 1995
Phase I clinical and pharmacokinetic study of 3'-deamino-3'-(2-methoxy-4-morpholinyl)doxorubicin (FCE 23762)P A Vasey, D Bissett, M Strolin-Benedetti, et al.
Pageof 5